Clinical Trials Logo

Filter by:
NCT ID: NCT06162988 Not yet recruiting - Tumor, Solid Clinical Trials

PET Imaging of 68Ga-NOTA-H006 in Malignancy

Start date: December 2023
Phase: N/A
Study type: Interventional

5T4, also known as trophoblast glycoprotein, is an oncofoetal antigen expressing in fetal development and cancer but rarely in adult. The high expression of 5T4 in malignancy was found be associated with poor clinical outcomes in ovarian, gastric and colorectal cancers. Several antibody drug conjugates are currently under development for cancer therapy in preclinic and clinic stages. Previously, investigators engineered a 5T4-specific biomolecule with nanomolar binding affinity. Radiolabeling with gallium-68 resulted in 68Ga-NOTA-H006 which showed 5T4 expression in a variety of xenograft models. Thus, the aims of current study are to evaluate the distribution and dosimetry of this novel tracer, and to explore the diagnostic values of 68Ga-NOTA-H006 in malignant tumors.

NCT ID: NCT06162962 Completed - Osteosarcoma Clinical Trials

Oncological and Functional Outcomes in Lower Limb Osteosarcoma Pediatric Patient

Start date: January 1, 2000
Phase:
Study type: Observational

Retrospective analysis of specific characteristics of complications and long-term oncological and function outcomes in lower-limb osteosarcoma pediatric patients.

NCT ID: NCT06162780 Recruiting - Clinical trials for Mitral Regurgitation

TEER for Severe DMR of Low to Intermediate Surgery Risk

Start date: January 1, 2024
Phase:
Study type: Observational [Patient Registry]

To investigate the efficacy and safety of transcatheter mitral valve edge-to-edge repair (TEER) for severe degenerative mitral regurgitation (DMR) patients of low to intermediate surgery risk.

NCT ID: NCT06162767 Recruiting - Clinical trials for Esophagogastric Junction Carcinoma

Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

This study is being done to see whether Optimized Sweet Procedure is superior than the Ivor-Lewis Procedure Esophagectomy with better long-term outcome and acceptable postoperative short-term outcome or not.

NCT ID: NCT06162702 Completed - Clinical trials for Fecal Microbiota Transplantation

Clinical Study of Fecal Microbiota Transplantation in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)

Start date: September 10, 2022
Phase: N/A
Study type: Interventional

Small intestinal bacterial overgrowth (SIBO) is defined as the presence of excessive numbers of bacteria in the small bowel causing gastrointestinal (GI) symptoms. These bacteria are usually coliforms, which are typically found in the colon and include predominantly Gram-negative aerobic and anaerobic species that ferment carbohydrates producing gas .Fecal Microbiota Transplantation (FMT) is a therapeutic method to transplant the microbiota from the feces of healthy people into the intestinal tract of patients. To explore the overall efficacy and safety of FMT in the treatment of SIBO.

NCT ID: NCT06162520 Completed - Clinical trials for Congenital Biliary Dilatation

Congenital Biliary Dilatation Diagnosis Based on 3D Morphological Characteristics

Start date: December 17, 2021
Phase:
Study type: Observational

Congenital biliary dilatation necessitates timely intervention owing to potential complications. This study endeavors to enhance diagnostic precision using quantitative three-dimensional morphological characteristics. Objectives involve developing models to differentiate congenital from secondary biliary dilatation and identify intrahepatic involvement. Employing machine learning, robust diagnostic models aim to elevate clinical detection rates and improve accuracy.

NCT ID: NCT06162338 Recruiting - Clinical trials for Gaucher Disease Type I

A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I

LY-M001
Start date: October 30, 2023
Phase: N/A
Study type: Interventional

This is a prospective single-center, open, single-arm, single-dose intravenous infusion study to evaluate the safety and initial efficacy, pharmacodynamic characteristics, immunogenicity, biodistribution, and viral shedding of LY-M001 injection.This study mainly includes the main study stage and the long-term follow-up study stage.

NCT ID: NCT06162325 Enrolling by invitation - Clinical trials for Acute Myeloid Leukemia

Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients

Start date: January 21, 2022
Phase:
Study type: Observational

The goal of this observational study is to to evaluate the efficacy and safety of Venetoclax in combination with DA60(daunorubicin 60 mg/m2/d for 3 days, and cytarabine 100 mg/m2 every 12 h for 7 days) induction and HD-AraC(cytarabine 3 g/m2 every 12 h for 3 days) consolidation, in young patients with newly diagnosed acute myeloid leukemia (AML).

NCT ID: NCT06162286 Recruiting - Clinical trials for Community-acquired Bacterial Pneumonia

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

public
Start date: November 17, 2023
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to show that in Chinese adults with CABP, a course of IV/PO treatment with omadacycline has similar clinical efficacy as the with the comparator antibiotic, IV/PO moxifloxacin. The study is designed as a bridging study, to confirm the results of the pivotal global CABP trial in an ethnically different population of Chinese.

NCT ID: NCT06162273 Not yet recruiting - Clinical trials for Aortic Aneurysm, Abdominal

An Exploratory Study of Iliac Artery Branch Stent for Internal Iliac Artery Reconstruction in Abdominal Aortic Aneurysm/Iliac Aneurysm Repair

Start date: December 1, 2023
Phase:
Study type: Observational

The purpose of this study is to evaluate the efficacy and safety of IBD stent of Shenzhen Xianjian Company and IBE stent of American Gore company in the treatment of abdominal aortic aneurysm/iliac aneurysm reconstruction of internal iliac artery